Surmodics, Inc. (SRDX) Social Stream
SURMODICS INC (SRDX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SURMODICS INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued November 10, 2022
The Trend in the Analyst Price Target
SRDX's average price target has moved up $5.75 over the prior 22 months.
Over the past 40 weeks, SRDX's average upside potential has been 96.65%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SRDX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
SRDX's average broker recommendation rating improved by 0 over the prior 61 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SRDX as an investment opportunity.
- SURMODICS INC's number of analysts covering the stock is greater than 6.92% of all US stocks.
- In the context of all US stocks, SURMODICS INC's variance in analysts' estimates is lower than 92.81% of them.
- SURMODICS INC's average analyst price target is greater than 287.9% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of Medical Equipment stocks, SURMODICS INC's upside potential (average analyst target price relative to current price) is greater than 228.8% of them.
What is the outlook for SRDX? Use POWR Ratings for clearer insight into price direction.